Yohimbine protects against endotoxin-induced acute lung injury by blockade of alpha 2A adrenergic receptor in rats

Chinese Medical Journal

Volumn 124, Issue 7, 2011, Pages 1069-1074

  Lin, Ying ^a   Zhu, Xi ^a   Yao, Wan Zhen ^a   Yang, Yan Lin ^a   A, La Ta ^a   Chen, Li ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

2a adrenergic receptor; Acute lung injury; Inflammatory response

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA; YOHIMBINE;

ACUTE LUNG INJURY; ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERIAL GAS; ARTICLE; ATELECTASIS; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; LEUKOCYTE COUNT; LUNG EDEMA; LUNG HEMORRHAGE; LUNG LAVAGE; MICROSCOPY; NONHUMAN; OXYGENATION; OXYGENATION INDEX; PROTEIN EXPRESSION; RAT;

ACUTE LUNG INJURY; ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; NOREPINEPHRINE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; TUMOR NECROSIS FACTOR-ALPHA; YOHIMBINE;

EID: 79954557012     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.07.022     Document Type: Article

References (22)

1. Kollef MH, Schuster DP. The acute respi ratory distress syndrome. N Engl J Med 1995; 332: 27-37.
2. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009; 179: 220-227.
3. Fein AM, Calalang-Colucci MG. Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock. Crit Care Clin 2000; 16: 289-317.
4. Chollet-Martin S, Jourdain B, Gibert C, Elbim C, Chastre J, Gougerot-Pocidalo MA. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 1996; 154: 594-601.
5. Flierl MA, Rittirsch D, Nadeau BA, Chen AJ, Sarma JV, Zetoune FS, et al. Phagocyte-derived catecholamines enh anc e acute inflammatory injury. Nature 2007; 449: 721-725.
6. Bergquist J, Ohisson B, Tarkowski A. Nuclear factor-κB is involved in the catecholaminergic suppression of immunocom petent cells. Ann N Y Acad Sci 2000; 917: 281-289.
7. Panosian JO, Marinetti GV. alpha 2-Adrenergic receptors in human polymorphonuclear leukoc yte membranes. Biochem Pharmacol 1983; 32: 2243-2247.
8. Bao JY, Huang Y, Wang F, Peng YP, Qiu YH. Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs in mediating modulation of T cell function. Neuroimmunomodulation 2007; 14: 344-353.
9. Miksa M, Wu R, Zhou M, Wang P. Sympathetic excitotoxicity in sepsis: pro-inflammatory priming of macropha ges by norepinephrine. Front Biosci 2005; 10: 2217-2229.
10. Tasaka S, Ishizaka A, Yamada W, Shimizu M, Koh H, Hasegawa N, et al. Effect of CD14 blockade on endotoxin-induced acute lung injur y in mice. Am J Respir Cell Mol Biol 2003; 29: 252-258.
11. Smith KM, Mrozek JD, Simonton SC, Bing DR, Meyers PA, Connett JE, et al. Prolonged partial liquid ventilation using conventional and high-frequency ventilatory techniques: gas exchange and lung pathology in an animal model of respiratory distress syndrome. Crit Care Med 1997; 25: 1888-1897.
12. Lee KH, Min HS, Han SW, Oh DY, Lee SH, Kim DW, et al. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer. Lung Cancer 2008; 60: 401-407.
13. De Laurentiis A, Pisera D, Caruso C, Candolfi M, Mohn C, Rettori V, et al. Lipopolysaccharide and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis. Neuroimmunomodulation 2002; 10: 30-39.
14. Dhingra VK, Uusaro A, Holmes CL, Walley KR. Attenuation of lung inflammation by adrenergic agonists in murine acute lung injury. Anesthesiology 2001; 95: 947-953.
15. Rassler B, Rohling MA, Reissig C, Briest W, Tannapfel A, Zimmer HG. Involvement of cytokines and inflammation in catecholamine-induced pulmonary injury in rats. Vasc Dis Prev 2005; 2: 1-9.
16. Dhingra VK, Uusaro A, Holmes CL, Walley KR. Attenuation of lung inflammation by adrenergic agonists in murine acute lung injury. Anesthesiology 2001; 95: 947-953.
17. Lin Y, Zhu X, He Y, Wang ZY, Cao XG. Effects of transaction of cervical spinal cord on lipopolysaccharide induced acute lung injury in rat. Chin Crit Care Med 2008; 120: 621-624.
18. de Oliveira Martins J, Meyer-Pflug AR, Alba-Loureiro TC, Melbostad H, Costa da Cruz JW, Coimbra R. Modulation of lipopolysaccharide-induced acute lung inflammation: role of insulin. Shock 2006; 25: 260-266.
19. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
20. Fessler HE, Otterbein L, Chung HS, Choi AM. Alpha-2 adrenoceptor blockade protects rats against lipopolysaccharide. Am J Respir Crit Care Med 1996; 154: 1689-1693.
21. Yalcin I, Aksu F, Belzung C. Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol. Eur J Pharmacol 2005; 514: 165-174.
22. Miksa M, Das P, Zhou M, Wu R, Dong W, Ji Y, et al. Pivotal role of the α2A-adrenoceptor in producing inflammation and organ injury in a rat model of sepsis. PLoS One 2009; 4: e5504.